R2 Technologies, Inc., the world leader in CryoAesthetics® with its cutting-edge Glacial Skin systems, has achieved several impressive milestones during 2024. Our Q2 and Q3 results are a testament to ...
DUBLIN, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- R2 Technologies Inc. ("R2"), the world leader in CryoAesthetics™ technology and the creator of Glacial® Rx, the first-to-market in-office precision ...
NEW YORK, April 23, 2020 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2”) (NYSE: HCHC), a diversified holding company, announced today that R2 Technologies (“R2”), a privately-held portfolio company ...
Glacial Skin delivers controlled cooling to reduce inflammation, brighten skin, and correct pigment, all with zero downtime. In Q2 2025, patient treatments increased 115% and average monthly ...
R2 achieved an extraordinary 111% year-over-year increase in system sales in North America from 2022 to 2023. Furthermore, the company experienced a 76% increase in sales from Q3 to Q4 alone, ...
NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- R2 Technologies, Inc., the world leader in CryoAesthetics ® with its cutting-edge Glacial Skin systems (“R2”), a portfolio company of INNOVATE Corp. (VATE) ...
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced that R2 Technologies, Inc. (“R2”), the innovators behind the breakthrough Glacial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback